Capricor Therapeutics Inc

-0.06 (-1.49%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)91.40M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.21 Million
Adjusted EPS-$0.23
See more estimates
10-Day MA$3.99
50-Day MA$4.31
200-Day MA$4.79
See more pivots

Capricor Therapeutics Inc Stock, NASDAQ:CAPR

8840 Wilshire Boulevard, 2nd floor, Beverly Hills, California 90211
United States of America
Phone: +1.310.358.3200
Number of Employees: 26


Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in Beverly Hills, CA.